Between and , acinetobacter species were the only .. forms provided by the authors are available with the full text of this article at Go to. Multidrug-resistant Acinetobacter baumannii (MDR-Ab) causes wound and bloodstream infections as well as ventilator-associated pneumonia. of human and animal origin in multiple countries (NEJM Journal Watch Acinetobacter spp., and Pseudomonas aeruginosa from inpatients.

Author: Muran Zolor
Country: Bermuda
Language: English (Spanish)
Genre: Life
Published (Last): 13 May 2005
Pages: 444
PDF File Size: 18.70 Mb
ePub File Size: 5.97 Mb
ISBN: 553-4-30012-949-7
Downloads: 85131
Price: Free* [*Free Regsitration Required]
Uploader: Faezil

A more recent clinical entity acinerobacter physicians need to be aware of is health care—associated pneumonia — that is, cases of pneumonia acquired in the community by patients who have had direct or indirect contact with a health care or wcinetobacter care facility and are subsequently hospitalized.

Compounding the problem of antimicrobial-drug resistance is the immediate threat of a reduction in the discovery and development of new antibiotics. The diagnosis of ventilator-associated pneumonia remains challenging, with no easily obtained reference standard.

An update from the Infectious Diseases Society of America. Carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Hospital-Acquired Infections Due to Gram-Negative Bacteria

Support Center Support Center. Moreover, a recent Food and Drug Administration alert informed physicians about the importance of using aerosolized colistimethate sodium soon after preparation to prevent lung toxicity from the active colistin form. The polymyxins colistin and polymyxin B are an older antibiotic class that has seen a resurgence of use in recent years and deserves mention.

Intercontinental emergence of Escherichia coli clone O In the majority of cases, the antibiotic coverage can then be reduced to a more targeted regimen based on the results of respiratory neejm or even discontinued, if an alternative diagnosis is identified. Hospital-acquired infections are most commonly associated with invasive medical devices or surgical procedures.

Catheter-associated urinary tract infection is rarely symptomatic: Types of Infections Hospital-acquired infections are a major challenge to patient safety.

Hospital-Acquired Infections Due to Gram-Negative Bacteria

For example, of bloodstream isolates of Klebsiella pneumoniae from hospitals throughout the United States, Implement written catheter-care protocols, including guidelines on catheter insertion Insert urinary catheter only when necessary and leave in only as long as indicated Consider other methods for management, including condom catheters or in-and-out catheterization, as appropriate Maintain a sterile, continuously closed drainage system Do acinetobater disconnect the catheter and drainage tube unless the catheter must be irrigated Maintain unobstructed urine flow Empty the collecting bag regularly, using a separate collecting container for each patient, and take care not to let the drainage spigot touch the collecting container Cleaning the meatal area with antiseptic solutions is unnecessary; routine hygiene is appropriate Do not routinely use silver-coated or other antibacterial Catheters Do axinetobacter screen for asymptomatic bacteriuria in acinetobscter patients Avoid catheter irrigation if possible Do not use systemic antibacterial agents routinely as Prophylaxis.


For patients in whom ventilator-associated pneumonia is suspected, a sample from the lower respiratory tract should be obtained by means of endotracheal aspiration, bronchoalveolar lavage, or a protected specimen brush depending on the resources available 1819 acinetobaccter microscopy and culture before antibiotics are administered.

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: Randomized trial of nejjm versus monotherapy acinetobactdr the empiric treatment of suspected ventilator-associated pneumonia. Tigecycline, a minocycline derivative with a broader spectrum of activity, is approved for the treatment of complicated skin, soft-tissue, and intraabdominal infections. Use local antimicrobial-susceptibility data and the length of the hospital stay before pneumonia developed to determine the most effective empirical antibiotic coverage.

We thank Howard Gold and David Paterson for their critical review of an earlier version of the manuscript.

Lower respiratory tract and bloodstream infections are the most lethal; however, urinary tract infections are the most common. Such patients are more likely to have a coexisting illness acinetobacfer to receive inactive empirical antibiotic therapy and are at greater risk for death than patients who have true community-acquired pneumonia.

The safety of targeted antibiotic therapy for ventilator-associated pneumonia: Estimating health care-associated infections and deaths in U. The results of earlier studies and meta-analyses are difficult to interpret, but more recent evidence is starting to clarify this issue.

Adherence to evidence-based interventions has proved highly successful Table 335 and hospitals worldwide should be adopting such cost-effective, preventive measures.

Apart from being associated with increased morbidity and mortality, suspected hospital-acquired pneumonia in the ICU can lead to the inappropriate use of antibiotic drugs, contributing to bacterial drug resistance and increases in toxic effects and health care costs.

Red spheres indicate antibiotics. Recent data from the U. N Engl J Med. Furthermore, it was shown to be inferior to imipenem—cilastatin for the treatment of ventilator-associated pneumonia in a randomized, double-blind trial.


When the antibiotic susceptibilities of the infecting organism are known, monotherapy and combination therapy have similar outcomes, including rates of emergence of resistance and recurrence of infection. Gram-negative organisms predominate in hospital-acquired urinary tract infections, almost all of which are associated with urethral catheterization.

To further improve such differentiation in patients with ventilator-associated pneumonia, promising biomarkers are being studied in combination with clinical and microbiologic factors. Please review our privacy policy. Infections caused by gram-negative bacteria have features that are of particular concern. Author manuscript; available in PMC Jun 3.

For empirical treatment, combination therapy improves the likelihood that a drug with in vitro activity against the suspected organism is being administered often defined as appropriate therapy. An intervention to decrease catheter-related bloodstream infections in the ICU. Growing evidence suggests that early, appropriate antibiotic therapy improves outcomes, 2425 and such therapy should therefore be a goal; however, this strategy needs to be coupled with an early reassessment of both diagnosis and therapy, usually within 48 to 72 hours.

Diagnosis of ventilator-associated pneumonia: Apart from clinical criteria, microbiologic assessment is important to help guide therapy. It is estimated that ina total of 1. Quantitative culture results are subject to possible sampling variability, and there is no evidence that quantitative cultures, as compared with qualitative cultures, are associated with reductions in mortality, the length of the ICU stay, the duration of mechanical ventilation, or the need to adjust antibiotic therapy.

Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Until further data are available, we do not recommend the use of antibiotic-impregnated or silver-coated urinary catheters. Organisms inherently resistant to polymyxins include serratia, proteus, Acinetobscter maltophiliaBurkholderia cepaciaand flavobacterium.

As has been described for the nonfermenting gram-negative organisms, K. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. The economic impact of infection control: When definitive antibiotic therapy is warranted, a relatively short course 8 days should be prescribed for patients with uncomplicated ventilator-associated pneumonia who receive appropriate antibiotic therapy initially.